A four-year follow-up survey of antimicrobial resistance among Acinetobacter baumannii complex from inpatients in Southern BrazilAMERICAN JOURNAL OF INFECTION CONTROLIF2.42021-12-013PRE
Impact of the blue-carba rapid test for carbapenemase detection on turnaround time for an early therapy against Pseudomonas aeruginosaAMERICAN JOURNAL OF INFECTION CONTROLIF2.42021-03-014PREAI
High minimum inhibitory concentrations among derepressed AmpC-beta-lactamase-producing Enterobacter cloacae complex isolates for ceftolozane with tazobactamINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32020-02-281OAAI
Forecasting from phenotypic testing to an antimicrobial stewardship strategy: Does the time to positivity of a blue-carba test predict the meropenem susceptibility level among carbapenemase producers?INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32019-06-140OAAI
The impact of efflux pumps on meropenem susceptibility among metallo-β-lactamase-producing and nonproducing Pseudomonas aeruginosa: Insights for better antimicrobial stewardshipINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32019-06-131OAAI
Equal, but different: Fluctuant biofilm formation and its impact on polymyxin B susceptibility among a clonal spreading of KPC-2-producing Klebsiella pneumoniae isolatesINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32019-05-202OAAI
Impact of biofilm production on polymyxin B susceptibility among Pseudomonas aeruginosa clinical isolatesINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32019-04-226OAAI
Why do susceptible bacteria become resistant to infection control measures? A Pseudomonas biofilm exampleINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32019-02-151OAAI
Nosocomial impact of prevalent β-lactamases from the community enterobacteriaceae: what to do when the resistance doesn't go your wayINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32018-06-252OAAI
From Dusk to Dawn: Understanding the Impact of Ertapenem Resistance Mechanisms on the In Vitro Potency of Other Drugs Among Enterobacter cloacae Complex IsolatesINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32018-02-132OAAI
An Increase in the Prevalence of KPC Nosocomial Bacteremia as a Trigger for Growing Polymyxin Resistance Among Other Multidrug-Resistant Non-KPC-Producing Enterobacteriaceae IsolatesINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32018-01-052OAAI
Epidemiology of Adaptive and Intrinsic Polymyxin Resistance Mechanisms by Comparing Polymyxin-Resistant Pathogen Prevalence in a One-Year Follow-Up SurveyINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32017-08-251OAAI
What's Lurking Around the Corner? Polymyxin B Resistance Among Klebsiella pnemoniae carbapenemase-producing Enterobacteriaceae, and Others, as a Burden of UseINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32017-07-110OAAI
Understanding the β-Lactam/Inhibitor of β-Lactamase Combinations: Reassessment for Better Antimicrobial StewardshipINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32017-06-012OAAI
Know Thy Self, Know Thy Enemy: A Current Survey and a Forecast for KPC-Producing Klebsiella pneumoniae Resistance Among Inpatients in Southern BrazilINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32017-04-114PREAI
Does Second Place Count? Lessons from a Major Discrepancy Between Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Enterobacter cloacae in a One-Year Follow-Up StudyINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32017-03-064OAAI
Improving Compliance With Antibiotic Stewardship: What Is the Role of Initial Microscopy on the Management of Mechanically Ventilated Patients?INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32016-12-201OAAI
Is the Polymyxin B Resistance Among Multidrug-Resistant Enterobacteriaceae (Except for the Carbapenemase-producing Ones) a Myth or a Matter?INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32016-11-214OAAI
Increase in Prevalence of KPC-2-Producing Klebsiella pneumoniae Recovered From Respiratory Secretions of Intensive Care Patients-Getting a Free Ride on a Menacing Colistin ResistanceINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32016-10-032OAAI
The Impact of Carbapenem-Resistant Enterobacteriaceae Type on Clinical Outcomes After the Recovery of This Organism From Urine of Critically Ill PatientsINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32016-08-081OAAI